Vicarious Surgical (NYSE:RBOT) Stock Price Up 3.8%

Vicarious Surgical Inc (NYSE:RBOT)’s share price traded up 3.8% on Thursday . The stock traded as high as $0.29 and last traded at $0.29. 211,198 shares were traded during mid-day trading, a decline of 67% from the average session volume of 648,866 shares. The stock had previously closed at $0.28.

Wall Street Analysts Forecast Growth

Separately, Piper Sandler dropped their price target on Vicarious Surgical from $1.50 to $1.00 and set a “neutral” rating on the stock in a research note on Tuesday, March 5th.

Vicarious Surgical Stock Performance

The company’s 50-day simple moving average is $0.34 and its 200-day simple moving average is $0.38.

Vicarious Surgical (NYSE:RBOT) last posted its quarterly earnings data on Monday, March 4th. The company reported ($0.07) EPS for the quarter, beating the consensus estimate of ($0.12) by $0.05. During the same period in the previous year, the company earned ($0.16) EPS. As a group, equities analysts anticipate that Vicarious Surgical Inc will post -0.39 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Vicarious Surgical

Several hedge funds have recently modified their holdings of the stock. Verition Fund Management LLC purchased a new position in Vicarious Surgical in the second quarter worth $36,000. Citigroup Inc. grew its position in Vicarious Surgical by 211.5% during the first quarter. Citigroup Inc. now owns 13,779 shares of the company’s stock worth $69,000 after buying an additional 9,356 shares during the period. Barclays PLC boosted its stake in shares of Vicarious Surgical by 541.6% during the 4th quarter. Barclays PLC now owns 14,840 shares of the company’s stock worth $30,000 after acquiring an additional 12,527 shares in the last quarter. Bank of New York Mellon Corp acquired a new position in Vicarious Surgical during the first quarter worth $77,000. Finally, BNP Paribas Arbitrage SNC purchased a new stake in Vicarious Surgical during the third quarter worth $57,000. 47.27% of the stock is owned by institutional investors and hedge funds.

Vicarious Surgical Company Profile

Vicarious Surgical Inc operates as a robotics technology company in the United States. The company focuses on developing and commercializing Vicarious System, a single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. Vicarious Surgical Inc was incorporated in 2014 and is headquartered in Waltham, Massachusetts.